January 23, 2014 | BY Jeff PlomleyCan liquid-chromatography-tandem mass spectrometry help us ride a new wave of biotherapeutics? Perhaps, but challenges remain.
January 13, 2014 | BY Mary McElroyCan synthetic biology revolutionize the field of stem cell therapy?
January 7, 2014 | BY Eureka StaffCharles River neuroscientist Toni Ahtoniemi’s article in GEN on kinematic analysis.
January 6, 2014 | BY Robert KaiserIntegrating safety pharmacology endpoints into toxicology studies makes sense. But uncertainty remain.
January 3, 2014 | BY Fraser McIntoshThe rise and rise of genetic testing as a preventive healthcare measure will become more mainstream and accessible.
December 20, 2013 | BY Jeff PlomleyWhile small synthetic molecules remain the mainstay of drug development, a new wave of complex, large-molecule protein biotherapeutics are on the horizon.
- December 17, 2013 | BY Charlie B. Clifford
The hottest trend in rodent vivarium diagnostics is PCR-based pathogen surveillance of entire spaces.
December 17, 2013 | BY Eureka StaffOne trend worth tracking is the recent flow of venture capital toward Central Nervous System (CNS) research.
December 16, 2013 | BY Ulrike HerbrandThere’s no shortage of ways to analyze a monoclonal. Now, for the hard part.
- December 12, 2013 | BY Mary McElroy
Eureka recently asked members of the Charles River scientific community what brewing scientific innovations and trends to look for in 2014. Here’s one example: Synthetic Biology.
